Delivery Order SPE2DB24D1205-SPE2DB25FCTJA

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of STELARA 90 MG/ML SYRINGEML. The contract, valued at $83,514.03, is a Firm Fixed Price Delivery Order with a completion date of June 25, 2024. AmerisourceBergen, a major pharmaceutical distribution company, will supply the medication to DLA facilities supporting the U.S. Department of Defense worldwide. This award is part of AmerisourceBergen's larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of STELARA 90 MG/ML syringes. The award, valued at $23,871.28, is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,563.04 firm fixed price delivery order is for the supply of STELARA 45 MG/0.5 ML syringes, with a completion date of July 11, 2024. This award is a part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which encompasses a comprehensive range of...
This federal contract award, valued at $80,684.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Stelara 90 mg/mL syringes, a specialty medication, with a completion date of November 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,167.21, is a Delivery Order with a Firm Fixed Price for the supply of STELARA 90 MG/ML SYRINGEML. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of STELARA 45 MG/0.5 ML syringes. The $18,032.17 firm-fixed-price delivery order has an ultimate completion date of August 30, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,269.40, is for the supply of Stelara 90 mg/ml syringes, a specialty medication. The contract is a firm fixed-price, with a completion date of January 13, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of STELARA 90 MG/ML SYRINGEML. The total ceiling value of the delivery order is $31,318.97, with an ultimate completion date of August 23, 2024. This contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Stelara 90 mg/ml syringes. The contract, valued at $7,263.24, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, worth up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,721.49, is a delivery order for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has a firm fixed price pricing type and a period of performance through January 23, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCTJA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Stelara 90 mg/mL syringes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $30,980.22 and a performance period ending on January 27, 2025. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current award does not have a set-aside designation, indicating open competition. The contract will provide critical specialty medications, vaccines, and other medical commodities to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/25/25, 10:20 AM